The prognosis of bladder cancer patients is related to pathological type, stage, etc. Some studies claimed that the 1-year, 3-year, and 5-year survival rates of bladder cancer patients are 95.12%, 82.14%, and 63.12%, respectively, and it is difficult to ascertain whether patients can survive for 20 years. Bladder cancer is the malignant tumor with the highest incidence rate in the urinary system, and its prognosis is related to the type of pathology, stage, patient’s own condition (age, smoking history, etc.), and treatment plan. At present, the treatment of bladder cancer is mainly based on surgical treatment, especially for muscle invasive bladder tumors, total cystectomy with pelvic lymph node dissection is often used in clinic, supplemented with various treatment options such as radiotherapy and chemotherapy, etc. However, there are still 50% to 70% of patients who have recurrence within 5 years after surgery. According to a domestic study, the 1-year, 3-year and 5-year survival rates of bladder cancer patients are 95.12%, 82.14% and 63.12% respectively. There are also studies that the 5-year overall survival rate of bladder cancer patients is 55.4%. Early detection and early treatment are conducive to improving the prognosis of patients, and bladder cancer patients should pay attention to it. If bladder cancer is suspected or diagnosed, it is recommended to go to regular hospitals for a comprehensive assessment of the condition, follow the doctor’s instructions to cooperate with the treatment, and choose the appropriate treatment plan, so as to avoid delaying the condition.